BioSpace News Archive

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Company will participate in fireside chats at two upcoming investor conferences.

Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI) today announced its Dutch subsidiary, Dyadic Nederland BV has entered into a strategic partnership agreement and collaboration with Rabian BV (“Rabian”), a Dutch innovative SME founded by experienced entrepreneurs and vaccine scientists.

Milestone Scientific Inc. announces it has commenced direct sales of its STA Single Tooth Anesthesia System® with Meridian Endo & Perio, a large endodontics, periodontics and implant dentistry practice with three offices in Wisconsin.

Electromed, Inc. today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Sidoti March Small-Cap Virtual Conference on March 13-14, 2024.

Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced positive preclinical data on weight loss effects for NPM-115, the Company’s miniature, twice-yearly, exenatide implant under development for the treatment of chronic weight management.

Femasys Inc. (NASDAQ: FEMY) today highlighted that its FemaSeed intratubal insemination product, a revolutionary approach to enhancing fertilization, is expected to serve as a first-line therapeutic option that is substantially lower cost with significantly less risk than assisted reproductive methods, such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the presentation of seven studies at the European Congress of Radiology 2024, to be held in Vienna, Austria, from February 28 to March 3.

Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced new data to be presented at The American Society for Radiation Oncology (ASTRO) Multidisciplinary Head and Neck Cancers Symposium (MHNCS) in Phoenix, AZ from February 29 – March 2, 2024.

Autonomous Medical Devices Incorporated has received a National Institutes of Health RADx Tech award from the National Institute of Biomedical Imaging and Bioengineering, part of the NIH.

Sana Biotechnology, Inc., a company focused on changing the possible for patients through engineered cells, announced that it will webcast its presentation at the Cowen 44th Annual Health Care Conference at 2:50 p.m. ET on Wednesday, March 6, 2024.